journal article·2023-01

Delivery of a peptide/microRNA blend via electrospun antimicrobial nanofibres for wound repair

Adrian D. Juncos Bombin, Nicholas Dunne, Helen O. McCarthy

Acta Biomaterialia· Volume 155
Publisher page

Abstract

Downregulation of microRNA-31 (miR-31) and microRNA-132 (miR-132) has been associated with delayed wound healing. Therefore, it was hypothesised that intracellular delivery of miR-31 and miR-132, both as individual and blend formulations, could promote tissue repair. The use of a blend could minimise potential toxicity and achieve synergistic effects, thus maximising the therapeutic effect. miR-31 and miR-132 were condensed with a 30-mer positively charged amphipathic peptide, RALA, to form nanocomplexes with an average size <200 nm and zeta-potential ≥10 designed to facilitate cellular internalisation. This enabled a fold increase in miR-31 and miR-132 expression of ≥100,000 in a murine fibroblast cell line (NCTC-929) and a skin human keratinocyte cell line (HaCaT), with intracellular delivery >70% for individual and blend formulations. Moreover, incubation with the nanocomplexes increased the migration of HaCaT cells ≥25% at 4 and 8 h post-incubation, as well as downregulation of EMP-1 and RASA1 and HB-EGF and RASA1, target genes for miR-31 and miR-132, respectively. Electrospinning was then employed to produce an alginate/polyvinyl alcohol/ciprofloxacin nanofibrous wound patch to facilitate the controlled delivery of the nanocomplexes. Nanofibres were crosslinked with glutaraldehyde to improve stability in aqueous solvents, and they were proven to be biocompatible with antimicrobial activity without cellular attachment to avoid injury upon removal. RALA/miR nanoparticles were incorporated to the nanofibrous wound dressing and in vivo wound healing studies using C57BL/6J mice demonstrated a >60% acceleration in the wound closure rate at Day 7 post-wounding, a ≥1.5 increase in epidermal thickness, and a ≥2 increase in blood vessel count with respect to commercial and untreated controls. Taken together, this data proves that delivery of RALA/miR-31 and RALA/miR-132 from an alginate/polyvinyl alcohol/ciprofloxacin nanofibrous wound dressing constitutes an advanced therapy for wound healing, by accelerating wound closure and improving healed tissue quality. STATEMENT OF SIGNIFICANCE: In this study, we report for the first time the use of the RALA peptide to deliver two miRNA 31 & 132 simultaneously from an electrospun patch. Both miRs have been shown to be downregulated in wounds and this study endeavoured to deliver a blend of the miRs from a nanofibre patch. Electrospinning was used to produce an alginate/polyvinyl alcohol/ciprofloxacin wound patch to enable controlled delivery of the miRs without cellular attachment to the wound with the added benefit of anti-microbial activity. Application of the nanofibre patch loaded with the blended RALA/miR nanoparticles demonstrated a synergistic effect with acceleration of wound closure rate, a significant increase in epidermal thickness and blood vessel count with respect to commercial and untreated controls.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Silk-based biomaterials and applications · Wound Healing and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (64)

Show source-provided references
1. Wound healing and skin regeneration10.1101/cshperspect.a023267 ↗
2. Wound healing: Biologic features and approaches to maximize healing trajectories10.1067/msg.2001.111167 ↗
3. Attempts to accelerate wound healing10.1016/j.jdermsci.2014.11.001 ↗
4. Mini-encyclopaedia of the wound healing - Opportunities for integrating multi-omic approaches into medical practice10.1016/j.jprot.2017.07.017 ↗
5. The economic impact of hard-to-heal wounds: promoting practice change to address passivity in wound management
6. Evidence-based management strategies for treatment of chronic wounds
7. Health economic burden that wounds impose on the National Health Service in the UK10.1136/bmjopen-2015-009283 ↗
8. An economic evaluation of the impact, cost, and medicare policy implications of chronic nonhealing wounds10.1016/j.jval.2017.07.007 ↗
9. L. McDermott-Scales, S. Cowman, G. Gethin, Prevalence of wounds in a community care setting in Ireland, 10.12968/Jowc.2009.18.10.44602. 18 (2013) 405–417. doi:10.12968/JOWC.2009.18.10.44602.10.12968/jowc.2009.18.10.44602 ↗
10. Gene Therapy for the Treatment of Chronic Wounds
11. MicroRNA silencing through RISC recruitment of eIF610.1038/nature05841 ↗
12. Noncoding RNAs in wound healing: a new and vast frontier10.1089/wound.2017.0765 ↗
13. Role of MicroRNA in proliferation phase of wound healing10.3389/fgene.2018.00038 ↗
14. MicroRNAs in diabetic wound healing: Pathophysiology and therapeutic opportunities10.1016/j.tcm.2018.08.002 ↗
15. MicroRNA as therapeutic targets for chronic wound healing10.1016/j.omtn.2017.06.003 ↗
16. In vivo delivery of miRNAs for cancer therapy: challenges and strategies10.1016/j.addr.2014.05.009 ↗
17. Combinatorial targeting by MicroRNAs co-ordinates post-transcriptional control of EMT10.1016/j.cels.2018.05.019 ↗
18. MicroRNA-31 promotes skin wound healing by enhancing keratinocyte proliferation and migration10.1038/jid.2015.48 ↗
19. MiR-31 mediates inflammatory signaling to promote re-epithelialization during skin wound healing10.1016/j.jid.2018.03.1521 ↗
20. MicroRNA-132 enhances transition from inflammation to proliferation during wound healing10.1172/JCI79052 ↗
21. MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis10.1038/nm.2186 ↗
22. Development of a novel RNAi therapy: Engineered miR-31 exosomes promoted the healing of diabetic wounds
23. Competitive binding of Rab21 and p120RasGAP to integrins regulates receptor traffic and migration10.1083/jcb.201012126 ↗
24. Development and characterization of self-assembling nanoparticles using a bio-inspired amphipathic peptide for gene delivery10.1016/j.jconrel.2014.06.048 ↗
25. DNA vaccination for cervical cancer; a novel technology platform of RALA mediated gene delivery via polymeric microneedles10.1016/j.nano.2016.11.019 ↗
26. Dissolving microneedles for DNA vaccination: Improving functionality via polymer characterization and RALA complexation10.1080/21645515.2016.1248008 ↗
27. Potentiating the anticancer properties of bisphosphonates by nanocomplexation with the cationic amphipathic peptide, RALA10.1021/acs.molpharmaceut.5b00670 ↗
28. Delivery of RALA/siFKBPL nanoparticles via electrospun bilayer nanofibres: an innovative angiogenic therapy for wound repair10.1016/j.jconrel.2019.10.050 ↗
29. FKBPL is a critical antiangiogenic regulator of developmental and pathological angiogenesis10.1161/ATVBAHA.114.304539 ↗
30. Electrospinning of natural polymers for the production of nanofibres for wound healing applications10.1016/j.msec.2020.110994 ↗
31. Recent advances in PVA-polysaccharide based hydrogels and electrospun nanofibers in biomedical applications: A review10.1016/j.ijbiomac.2021.08.002 ↗
32. Poly(vinyl alcohol)-based nanofibrous electrospun scaffolds for tissue engineering applications10.3390/polym12010007 ↗
33. Imbibed salts and pH-responsive behaviours of sodiumalginat based eco-friendly biopolymeric hydrogels-Asolventless approach
34. Naturally derived materials-based cell and drug delivery systems in skin regeneration10.1016/j.jconrel.2009.10.018 ↗
35. Alginate hydrogels as biomaterials10.1002/mabi.200600069 ↗
36. Ciprofloxacin: Review on developments in synthetic, analytical, and medicinal aspects10.3109/14756360903373350 ↗
37. State-of-the-Art review of electrospun gelatin-based nanofiber dressings for wound healing applications10.3390/nano12050784 ↗
38. Novel bi-layered dressing patches constructed with radially-oriented nanofibrous pattern and herbal compound-loaded hydrogel for accelerated diabetic wound healing
39. Novel electrospun chitosan/polyvinyl alcohol/zinc oxide nanofibrous mats with antibacterial and antioxidant properties for diabetic wound healing10.1016/j.ijbiomac.2018.08.057 ↗
40. Tinidazole functionalized homogeneous electrospun chitosan/poly (ε-caprolactone) hybrid nanofiber membrane: Development, optimization and its clinical implications10.1016/j.ijbiomac.2017.05.161 ↗
41. Species-specific segmentation clock periods are due to differential biochemical reaction speeds10.1126/science.aba7668 ↗
42. Epithelialization in wound healing: a comprehensive review10.1089/wound.2013.0473 ↗
43. A review on polymeric hydrogel membranes for wound dressing applications: PVA-based hydrogel dressings10.1016/j.jare.2017.01.005 ↗
44. The bactericidal activity of glutaraldehyde-impregnated polyurethane10.1002/mbo3.378 ↗
45. Antimicrobial dressings
46. Living with a venous leg ulcer: a descriptive study of patients'experiences10.1111/j.1365-2648.1995.tb03110.x ↗
47. Role of particle-particle interaction towards effective interpretation of Z-average and particle size distributions from Dynamic Light Scattering (DLS) analysis10.1166/jnn.2018.15458 ↗
48. A. Cavazza, A. Moiani, F. Mavilio, Mechanisms of retroviral integration and mutagenesis, https://Home.Liebertpub.Com/Hum. 24 (2013) 119–131. 10.1089/HUM.2012.203.10.1089/hum.2012.203 ↗
49. Degradation dynamics of microRNAs revealed by a novel pulse-chase approach10.1101/gr.198788.115 ↗
50. Recent development of polymer nanofibers for biomedical and biotechnological applications10.1007/s10856-005-4428-x ↗
51. An overview on application of natural substances incorporated with electrospun nanofibrous scaffolds to development of innovative wound dressings10.2174/1389557517666170308112147 ↗
52. Aligned biodegradable nanofibrous structure: a potential scaffold for blood vessel engineering10.1016/S0142-9612(03)00593-3 ↗
53. Electrospun nanofibers as dressings for chronic wound care: advances, challenges, and future prospects10.1002/mabi.201300561 ↗
54. Cross-linking of cellulose nanofiber films with glutaraldehyde for improved mechanical properties10.1016/j.matlet.2019.05.002 ↗
55. ISO 10993-5:2009, Biological evaluation of medical devices – Part 5: Tests for in vitro cytotoxicity, (2009) 34. https://www.iso.org/standard/36406.html (accessed April 30, 2019).
56. Crosslinking biopolymers for biomedical applications10.1016/j.tibtech.2015.03.008 ↗
57. Electrospinning of silk fibroin nanofibers and its effect on the adhesion and spreading of normal human keratinocytes and fibroblasts in vitro10.1016/j.biomaterials.2003.08.045 ↗
58. Formation of nanostructured poly(lactic-co-glycolic acid)/chitin matrix and its cellular response to normal human keratinocytes and fibroblasts10.1016/j.carbpol.2004.05.007 ↗
59. Development of antimicrobial chitosan based nanofiber dressings for wound healing applications
60. Ciprofloxacin-Eluting nanofibers inhibits biofilm formation by Pseudomonas aeruginosa and a methicillin-resistant Staphylococcus aureus10.1371/journal.pone.0123648 ↗
61. Caring for surgical wounds at home. Information for patients
62. Determination of tensile strength of electrospun single nanofibers through modeling tensile behavior of the nanofibrous mat10.1016/j.compositesb.2011.04.024 ↗
63. Curcumin nanofibers for the purpose of wound healing10.1002/jcp.27362 ↗
64. An improved humanized mouse model for excisional wound healing using double transgenic mice10.1089/wound.2017.0772 ↗